Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowes, M. P.
Right arrow Articles by Zivin, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowes, M. P.
Right arrow Articles by Zivin, J. A.
NEUROLOGY 1995;45:815-819
© 1995 American Academy of Neurology

Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy

Mark P. Bowes, PhD, Robert Rothlein, Phd, Susan C. Fagan, PharmD and Justin A. Zivin, MD, PhD

Article abstract-We evaluated the ability of monoclonal antibodies directed against leukocyte adhesion molecules (intercellular adhesion molecule-1 (ICAM-1), CD18) to enhance the efficacy of thrombolysis in a rabbit cerebral embolism stroke model. Both tissue-type plasminogen activator (tPA) and anti-CD18 (alpha-CD18) monoclonal antibody administered 5 minutes after embolization increased the quantity of clots required to produce neurologic damage, although the combination was no more effective than either substance alone. Neither alpha-CD18 nor anti-ICAM-1 (alpha-ICAM-1) improved neurologic outcome at postischemic delays of 15 or 30 minutes. However, the combination of alpha-ICAM-1 (15 minutes after embolization) and tPA (2 hours after embolization) significantly improved neurologic outcome even though neither substance was effective alone at these postembolization delays. These findings suggest that prevention of leukocyte adhesion increases the postischemic duration at which thrombolytic therapy remains effective.

NEUROLOGY 1995;45: 815-819




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
D.J. Kim, D.I. Kim, S.K. Lee, S.H. Suh, Y.J. Lee, J. Kim, T.S. Chung, and J.E. Lee
Protective effect of agmatine on a reperfusion model after transient cerebral ischemia: Temporal evolution on perfusion MR imaging and histopathologic findings.
AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 780 - 785.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Fisher, A. Davalos, A. Rogalewski, A. Schneider, E. B. Ringelstein, and W.-R. Schabitz
Toward a Multimodal Neuroprotective Treatment of Stroke
Stroke, April 1, 2006; 37(4): 1129 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. A. Naidu, E. S. Fu, E. T. Sutton, L. D. Prockop, and A. Cantor
The Therapeutic Effects of Epidural Intercellular Adhesion Molecule-1 Monoclonal Antibody in a Rabbit Model: Involvement of the Intercellular Adhesion Molecule-1 Pathway in Spinal Cord Ischemia
Anesth. Analg., September 1, 2003; 97(3): 857 - 862.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, M. Krams, and M. Chopp
Effects of a Selective CD11b/CD18 Antagonist and Recombinant Human Tissue Plasminogen Activator Treatment Alone and in Combination in a Rat Embolic Model of Stroke
Stroke, July 1, 2003; 34(7): 1790 - 1795.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C.J.M. Frijns and L.J. Kappelle
Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease
Stroke, August 1, 2002; 33(8): 2115 - 2122.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. S. Han, Y. Qiao, M. Karabiyikoglu, R. G. Giffard, and M. A. Yenari
Influence of Mild Hypothermia on Inducible Nitric Oxide Synthase Expression and Reactive Nitrogen Production in Experimental Stroke and Inflammation
J. Neurosci., May 15, 2002; 22(10): 3921 - 3928.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. A. Lapchak, D. M. Araujo, D. Song, J. Wei, and J. A. Zivin
Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model: Combination Studies With the Thrombolytic Tissue Plasminogen Activator
Stroke, May 1, 2002; 33(5): 1411 - 1415.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial
Neurology, October 23, 2001; 57(8): 1428 - 1434.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
Recommendations for Clinical Trial Evaluation of Acute Stroke Therapies
Stroke, July 1, 2001; 32(7): 1598 - 1606.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kielian, B. Barry, and W. F. Hickey
CXC Chemokine Receptor-2 Ligands Are Required for Neutrophil-Mediated Host Defense in Experimental Brain Abscesses1
J. Immunol., April 1, 2001; 166(7): 4634 - 4643.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Fisher and W. Schaebitz
An Overview of Acute Stroke Therapy: Past, Present, and Future
Arch Intern Med, November 27, 2000; 160(21): 3196 - 3206.
[Full Text] [PDF]


Home page
StrokeHome page
L. S. Ritter, J. A. Orozco, B. M. Coull, P. F. McDonagh, and W. I. Rosenblum
Leukocyte Accumulation and Hemodynamic Changes in the Cerebral Microcirculation During Early Reperfusion After Stroke Editorial Comment
Stroke, May 1, 2000; 31(5): 1153 - 1161.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. C. Hess, E. Howard, C. Cheng, J. Carroll, W. D. Hill, and C. Y. Hsu
Hypertonic Mannitol Loading of NF-{kappa}B Transcription Factor Decoys in Human Brain Microvascular Endothelial Cells Blocks Upregulation of ICAM-1 Editorial Comment
Stroke, May 1, 2000; 31(5): 1179 - 1186.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. A. Zivin
Thrombolytic stroke therapy: Past, present, and future
Neurology, July 1, 1999; 53(1): 14 - 14.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. J. Prestigiacomo, S. C. Kim, E. S. Connolly Jr, H. Liao, S.-F. Yan, D. J. Pinsky, and G. Feuerstein
CD18-Mediated Neutrophil Recruitment Contributes to the Pathogenesis of Reperfused but Not Nonreperfused Stroke • Editorial Comment
Stroke, May 1, 1999; 30(5): 1110 - 1117.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. L. Zhang, Z. G. Zhang, M. Chopp, and J. A. Zivin
Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain • Editorial Comment
Stroke, March 1, 1999; 30(3): 624 - 629.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Vuorte, P. J. Lindsberg, M. Kaste, S. Meri, S.-E. Jansson, R. Rothlein, and H. Repo
Anti-ICAM-1 Monoclonal Antibody R6.5 (Enlimomab) Promotes Activation of Neutrophils in Whole Blood
J. Immunol., February 15, 1999; 162(4): 2353 - 2357.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. L. Zhang, Z. G. Zhang, and M. Chopp
Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat
Neurology, January 1, 1999; 52(2): 273 - 273.
[Abstract] [Full Text]


Home page
StrokeHome page
A. Bitsch, W. Klene, L. Murtada, H. Prange, and P. Rieckmann
A Longitudinal Prospective Study of Soluble Adhesion Molecules in Acute Stroke
Stroke, October 1, 1998; 29(10): 2129 - 2135.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Pantoni, C. Sarti, and D. Inzitari
Cytokines and Cell Adhesion Molecules in Cerebral Ischemia : Experimental Bases and Therapeutic Perspectives
Arterioscler Thromb Vasc Biol, April 1, 1998; 18(4): 503 - 513.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. S. Connolly Jr, C. J. Winfree, C. J. Prestigiacomo, S. C. Kim, T. F. Choudhri, B. L. Hoh, Y. Naka, R. A. Solomon, and D. J. Pinsky
Exacerbation of Cerebral Injury in Mice That Express the P-Selectin Gene : Identification of P-Selectin Blockade as a New Target for the Treatment of Stroke
Circ. Res., September 19, 1997; 81(3): 304 - 310.
[Abstract] [Full Text]


Home page
StrokeHome page
C. Iadecola, F. Zhang, R. Casey, H. B. Clark, M. E. Ross, and R. C Kukreja
Inducible Nitric Oxide Synthase Gene Expression in Vascular Cells After Transient Focal Cerebral Ischemia
Stroke, August 1, 1996; 27(8): 1373 - 1380.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.